Antimicrobial Synergy Testing: Comparing the Tobramycin and Ceftazidime Gradient Diffusion Methodology Used in Assessing Synergy in Cystic Fibrosis-Derived Multidrug-Resistant Pseudomonas aeruginosa

The need for synergy testing is driven by the necessity to extend the antimicrobial spectrum, reducing drug dosage/toxicity and the development of resistance. Despite the abundance of synergy testing methods, there is the absence of a gold standard and a lack of synergy correlation among methods. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Okoliegbe, Ijeoma N., Hijazi, Karolin, Cooper, Kim, Ironside, Corinne, Gould, Ian M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388873/
https://www.ncbi.nlm.nih.gov/pubmed/34439017
http://dx.doi.org/10.3390/antibiotics10080967

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388873/
https://www.ncbi.nlm.nih.gov/pubmed/34439017
http://dx.doi.org/10.3390/antibiotics10080967

Ejemplares similares